Robinson John Edward, Chief Scientific Officer of Cogent Biosciences ($COGT), made one open market sale of company shares in the last 365 days, totaling $3.5 million. His most recent sale occurred on December 26, 2025. These sales rank 2,450th among 11,678 individual insiders in the database by total value sold, below the average of $8.6 million across 6.4 transactions per insider. He reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 26, 2025 | Cogent Biosciences, Inc. | $COGT | Robinson John Edward | Chief Scientific Officer | S | Common Stock | 90000 | $38.74 | 140,002.0000 | 142,376,529 | 39.13% | 0.06% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Robinson John Edward | Chief Scientific Officer | A | Common Stock | 50000 | $0.00 | 50,000.0000 | 142,376,529 | 9999.99% | 0.04% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Robinson John Edward | Chief Scientific Officer | A | Common Stock | 320000 | $0.00 | 370,000.0000 | 142,376,529 | 640.00% | 0.22% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Robinson John Edward | Chief Scientific Officer | F | Common Stock | 139998 | $39.45 | 230,002.0000 | 142,376,529 | 37.84% | 0.10% |
| Dec. 17, 2025 | Cogent Biosciences, Inc. | $COGT | Robinson John Edward | Chief Scientific Officer | A | Stock Option (Right to Buy) | 65000 | $0.00 | 65,000.0000 | 142,376,529 | 9999.99% | 0.05% |
| Jan. 23, 2025 | Cogent Biosciences, Inc. | $COGT | Robinson John Edward | Chief Scientific Officer | A | Stock Option (Right to Buy) | 270000 | $0.00 | 270,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2024 | Cogent Biosciences, Inc. | $COGT | Robinson John Edward | Chief Scientific Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 0 | 9999.99% | 0.00% |